Dow Up0.12% Nasdaq Up1.35%

Repros Therapeutics Inc. (RPRX)

6.23 Down 0.08(1.27%) Oct 20, 4:00PM EDT
Insider TransactionsGet Insider Transactions for:
Net Share Purchase Activity
Insider Purchases - Last 6 Months
Net Shares Purchased
Total Insider Shares Held2.27MN/A
% Net Shares Purchased
Net Institutional Purchases - Prior Qtr to Latest Qtr
Net Shares Purchased
% Change in Institutional Shares Held17.2%
Data provided by Thomson Financial

Insider Transactions Reported - Last Two Years
Sep 15, 2014MASTERSON NOLA EDirector200IndirectPurchase at $14.34 per share.2,868
Aug 14, 2014PODOLSKI JOSEPHOfficer2,100DirectPurchase at $13.91 per share.29,211
Aug 14, 2014ANDERSON KATHERINEOfficer2,000DirectPurchase at $13.85 per share.27,700
Jan 10, 2014CAIN DANIEL FDirector10,000DirectOption Exercise at $9.60 per share.96,000
Nov 12, 2013CAIN DANIEL FDirector500DirectPurchase at $14.97 per share.7,485
Oct 25, 2013PODOLSKI JOSEPHOfficer3,000DirectPurchase at $18.03 per share.54,090
Oct 25, 2013ANDERSON KATHERINEOfficer1,000DirectPurchase at $17.90 per share.17,900
Oct 10, 2013ANDERSON KATHERINEOfficer1,000DirectPurchase at $23.77 per share.23,770
Mar 15, 2013PERCEPTIVE ADVISORS LLCBeneficial Owner (10% or more)2,050,000IndirectDividend Reinvestment at $10 - $15 per share.N/A
Feb 1, 2013ANDERSON KATHERINEOfficer1,000DirectPurchase at $11.89 per share.11,890
Oct 29, 2012WYLLIE MICHAELDirector1,068DirectDisposition (Non Open Market) at $13.83 per share.14,770
Oct 29, 2012WYLLIE MICHAELDirector3,333DirectOption Exercise at $4.43 per share.14,765
Data provided by EDGAR Online
* = Where indicated, some values are estimates.
1= Potential proceeds estimated by the filer.
2= Estimated based on the average of multiple prices reported.
3= Multiple dates reported. Most recent date shown.

Currency in USD.

All Major Holders - Insider Roster